
Dr James Yarmolinsky
PhD, MSc, BSc
Current positions
Honorary Senior Research Fellow
Bristol Medical School (PHS)
Contact
Press and media
Many of our academics speak to the media as experts in their field of research. If you are a journalist, please contact the University’s Media and PR Team:
Biography
James Yarmolinsky is a Cancer Research UK Postdoctoral Fellow whose research aims to use insights from human genetics and other quasi-experimental designs to inform the development of pharmacological interventions for cancer prevention and treatment. He is currently leading a collaborative project (INflammation in Cancer Aetiology, INCA, https://www.bristol.ac.uk/integrative-epidemiology/programmes/icep/collaborations/inca-inflammation-in-cancer-aetiology/) within the MRC Integrative Epidemiology Unit at the University of Bristol which aims to evaluate the role of circulating inflammatory markers in cancer risk and progression using Mendelian randomization. Prior to obtaining his PhD in Epidemiology from the University of Bristol in 2020, James completed an MSc in Epidemiology at the London School of Hygiene & Tropical Medicine and then worked for two years as a Research Assistant with the Brazilian Longitudinal Study of Adult Health at the Federal University of Rio Grande do Sul in Porto Alegre, Brazil.
Projects and supervisions
Thesis supervisions
Publications
Recent publications
31/03/2025Why exposure misidentification is a pervasive pitfall of Mendelian randomization studies with medication use as the exposure
International Journal of Epidemiology
Transcriptome-wide Mendelian randomisation exploring dynamic CD4+ T cell gene expression in colorectal cancer development
Transcriptome-wide Mendelian randomisation exploring dynamic CD4+ T cell gene expression in colorectal cancer development
Adiposity distribution and risks of twelve obesity-related cancers
PLoS Medicine
Association between circulating inflammatory markers and adult cancer risk
EBioMedicine
Identification of potential mediators of the relationship between body mass index and colorectal cancer: a Mendelian randomization analysis
International Journal of Epidemiology
Thesis
Interrogating causality in the association of molecular and lifestyle factors with prostate and ovarian cancer risk
Supervisors
Award date
24/03/2020